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Improving Breast Cancer Outcomes Through Patient Navigation
Lisa C. Richardson, MD, MPH
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease 
Control and Prevention, Atlanta, Georgia
Breast cancer deaths have been decreasing for several decades with half of the improvement 
attributed to mammographic screening.1 Cancer screening is not just a screening test but also 
involves a complex sequence of events at which women can be lost because of individual, 
provider, health system, and societal factors.2 If diagnostic follow-up and treatment are 
needed, navigation has a role beyond the initial screening tests. Helping women navigate the 
health-care system to get to and through treatment is critical for optimal outcomes. Studies 
using the National Cancer Institute’s CISNET models have found that appropriate treatment 
will provide the best outcomes and likely decrease mortality, especially in underserved 
women.3,4 Patient navigation is a novel intervention that has been implemented widely and 
the purpose of which is to help patients traverse the complex healthcare system.5 The 
objective of patient navigation is that women who participate, especially those from 
underserved populations, breast cancer outcomes will improve by decreasing the amount of 
time it takes for women to receive follow-up services and avoiding loss to follow-up. If 
diagnostic follow-up and treatment are not obtained, the full benefit of screening is not 
realized.
The article by Oppong et al. in this issue describes the patient navigation program 
implemented in the Capital Breast Care Center (CBCC) in Washington, DC. The article 
examined the interval to diagnosis after an abnormal mammogram for women receiving 
patient navigation services through CBCC.6 Oppong et al. found that from 2010 to 2012, 
just less than 10% of women who received screening mammograms through CBCC were 
recommended to have additional follow-up; 80% of those who were recommended for 
follow-up returned for diagnostic imaging within a median of 39 days. Of the 162 women 
recommended for biopsy, 81.5% received the biopsy within a median of 21 days. The 
authors indicate that these intervals are within performance standards for CDC’s National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP), which recommend that 
women complete a diagnostic workup within 60 days of an abnormal screening 
mammogram.7
Within a broader context, these findings highlight some important opportunities to address 
disparities in follow-up intervals in breast cancer screening for underserved women. Similar 
to the NBCCEDP, black and Hispanic women in the study had differing proportions 
Address correspondence to: Lisa C. Richardson, MD, MPH, National Center for Chronic Disease Prevention and Health Promotion 
Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F-76, Atlanta, GA 30341, lfr8@cdc.gov. 
Author Disclosure Statement
No competing financial interests exist.
HHS Public Access
Author manuscript
J Womens Health (Larchmt). Author manuscript; available in PMC 2017 December 01.
Published in final edited form as:













completing follow-up.7 These findings suggest that patient navigation will need to be 
tailored to meet the unique needs of different racial and ethnic groups. Any abnormal 
mammogram result does need to get timely workup, diagnosis, and treatment as a way to 
reduce loss to follow-up and maintain continuous treatment for a cancer that can be detected 
early. Studies from Canada have reported that women who have a 6- to 12-month delay to 
diagnosis after mammogram have larger cancers and more positive lymph nodes, leading to 
a poorer prognosis.8 These cancers are harder to cure.
This article adds to the body of evidence on patient navigation implemented in different 
parts of the cancer continuum. A general recent review of patient navigation in breast cancer 
treatment adherence did not find any effect on adherence to follow-up,9 whereas a study in a 
public hospital reported that navigation helped women complete breast cancer treatment.10 
More studies are needed to fully understand the benefits of patient navigation, including 
possible tailoring or customization for women of greatest need.
The CBCC reports that a navigation program instituted in the clinic assists women in 
receiving diagnostic follow-up in a timely way.6 This success is to be celebrated. The 
District of Columbia set a goal of decreasing breast cancer mortality by 10% by 202011 A 
modeling study using data from DC showed that continuing screening at current intervals 
and ensuring quality treatment is received should help DC meet this goal.4 Ensuring quality 
care along the breast cancer screening continuum as reported by Oppong et al. will decrease 
health disparities noted among black and white women.6 To ensure quality cancer care, the 
Center for Medicare and Medicaid created the Oncology Care Model to improve cancer care 
in clinics and health care systems.12 A key component of the program is patient navigation 
that will complement current provider practices to ensure patient access to care when 
needed.
Where do we go from here? Oppong et al. reported that 31% of women had more than 60 
days of follow-up with outliers up to 400 days. Previous work has shown that women who 
were diagnosed after an abnormal mammogram who had follow-up between 6 and 12 
months had cancers with a worse prognosis.8 We need better understanding of individual 
characteristics and health system factors that were barriers for women completing follow-up. 
Understanding barriers and facilitators is needed to help design interventions to help all 
women benefit equally from screening.
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